drugset / Trial / NCT06587698
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be carried out under the guidance of professional doctor, patients with PCOS will be treated with Sitagliptin or BeiDouGen capsule or both two to assess their ovarian function and reproductive outcomes, and compare the effect of different treatment methods, which will provide the basis for PCOS intervention strategy and related research
Timeline
- Start
- 2024-08-21
- Primary completion
- 2028-07-01
- Completion
- 2029-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BeiDouGen | Unknown | 60 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |